Technology | May 18, 2010

Proton Therapy Becoming More Accessible to U.S. Patients

A proton therapy treatment vault at the Rinecker Proton Therapy Center (RPTC) in Munich, Germany.

May 18, 2010 - Proton beam therapy is becoming more accessible in the United States.

While proton beam therapy has proved to be more precise in delivering dose to tumors compared to conventional external beam radiation, the larger proton beam accelerator is more expensive, and the process requires special training.

However, recent advances in the technology is making it more accessible. Varian Medical Systems is introducing the fully-integrated ProBeam proton therapy system at the 2010 Particle Therapy Co-operative Group (PT-COG) meeting here this week. ProBeam is designed to simplify the proton therapy treatment process for clinicians and patients alike.

The system incorporates imaging, gating, robotic patient positioning, treatment planning and oncology information software to enhance treatment quality for patients and workflow efficiency for clinicians.

The integrated system can be used for all forms of advanced proton therapy, including image-guided proton therapy and intensity-modulated proton therapy.

The ProBeam system incorporates Dynamic Peak integrated scanning technology, which is designed to paint a precise radiation dose on the target volume, enabling intensity modulated proton therapy. The system also incorporates proprietary pencil-beam scanning technology, which allows for precise dose distribution.

Using Varian's 250 MeV super-conducting cyclotron and features, the ProBeam system includes a streamlined treatment console with a modern, graphical interface that consolidates all controls for imaging, treatment and motion management. Treatment process and workflows use a follow the light-guidance system that is designed to enhance usability and promote safety by guiding therapists through the steps of even the most complex treatments.

The ProBeam interface has the same design as Varian's recently-announced TrueBeam system for radiation therapy and TrueBeam STx system for radiosurgery.

For more information: www.varian.com

Related Content

Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
GE Healthcare Discovery RF Gen 2 system displayed at ASTRO 2018. It is a dedicated computed tomography (CT) scanner for radiation oncology
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
Videos | Radiation Oncology | November 06, 2018
Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation
The patient’s wife changes the Optune array. Clinical trials indicate that the electrical fields emitted by Optune have the potential to lengthen the lives of patients with glioblastoma.

The patient’s wife changes the Optune array. Clinical trials indicate that the electrical fields emitted by Optune have the potential to lengthen the lives of patients with glioblastoma.

Feature | Radiation Oncology | November 06, 2018 | By Greg Freiherr
Approximately 11,000 professionals attended the four-day meeting of the...